News tagged with tamiflu
Half of Tamiflu prescriptions weren't taken in 2009 swine flu pandemic
Around half the antiviral drug Tamiflu that was prescribed during the 2009 H1N1 swine flu pandemic was never used, researchers have discovered.
Medications
Apr 17, 2013 |
not rated yet |
0
|
Tamiflu doesn't offer relief promised, study finds
For the nearly 62 million Americans infected with influenza each year, oeseltamivir, commonly called Tamiflu, promises to offer relief. New research from the University of Georgia finds the medication may not have all of ...
Medications
Oct 26, 2012 |
4 / 5 (2) |
1
|
CDC: Influenza activity increasing across the U.S.
(HealthDay)—Flu season descended on the United States early and hard this winter, with significant increases in flu activity observed over the past month, according to an update issued Jan. 4 by the U.S. ...
Diseases, Conditions, Syndromes
Jan 05, 2013 |
not rated yet |
1
Flu data used to determine vaccine effectiveness
(Medical Xpress)—Armed with data on vaccine effectiveness from five study monitoring sites, including one at the University of Michigan School of Public Health, the Centers for Disease Control is renewing the call for everyone ...
Diseases, Conditions, Syndromes
Jan 14, 2013 |
not rated yet |
0
48 states now report flu activity, 29 children dead: CDC
(HealthDay)—Forty-eight states are now reporting widespread flu activity, up from 47 last week, U.S. health officials reported Friday.
Diseases, Conditions, Syndromes
Jan 18, 2013 |
not rated yet |
0
British medical journal slams Roche on Tamiflu (Update)
A leading British medical journal is asking the drug maker Roche to release all its data on Tamiflu, claiming there is no evidence the drug can actually stop the flu.
Medications
Nov 12, 2012 |
not rated yet |
0
Effects of Tamiflu still uncertain, warn experts, as Roche continues to withhold key trial data
Two years after pharmaceutical giant Roche promised the BMJ it would release key Tamiflu trial data for independent scrutiny, the safety and effectiveness of this anti-influenza drug remains uncertain, warn experts today. ...
Medications
Jan 18, 2012 |
not rated yet |
0
|
A new approach to deadly influenza outbreaks in nursing homes
(Medical Xpress)—In developed countries people over 65 years old are the most likely to die from an influenza outbreak and people in nursing homes, where the virus is difficult to control, are especially vulnerable.
Diseases, Conditions, Syndromes
Oct 18, 2012 |
not rated yet |
0
|
'Spot' shortages of flu vaccine, tamiflu reported, FDA head says
(HealthDay)—Sporadic shortages of both the flu vaccine and the flu treatment Tamiflu are being reported, as this year's intense flu season continues, according to a top U.S. health official.
Medications
Jan 15, 2013 |
not rated yet |
0
Cochrane group skeptical about latest Roche pledges
(HealthDay)—Following requests from Cochrane researchers, Roche has pledged to release full clinical study reports for Tamiflu, although there appear to be conditions attached, according to correspondence ...
Medications
Mar 07, 2013 |
not rated yet |
0
Just how severe is this flu season?
(HealthDay)—If the headlines are any indication, this year's flu season is turning out to be a whopper.
Diseases, Conditions, Syndromes
Jan 16, 2013 |
not rated yet |
0
Swine flu strain that is resistant to Tamiflu is spreading more easily
The flu season is still young in the United States and the rest of the Northern Hemisphere, but Australia wrapped up its flu season months ago, and public health officials there have some disturbing news to report: The version ...
Diseases, Conditions, Syndromes
Dec 29, 2011 |
5 / 5 (2) |
0
Early use of antiviral medications may help prevent lung failure in children with the flu, reduce hospitalizations
(Medical Xpress)—Children hospitalized for the flu are much less likely to require breathing support from a mechanical ventilator if they receive antiviral drugs like oseltamivir (Tamiflu) as soon as possible after admission, ...
Diseases, Conditions, Syndromes
Nov 08, 2012 |
not rated yet |
0
CDC: Flu seems to level off except in the West
New government figures show that flu cases seem to be leveling off nationwide. Flu activity is declining in most regions although still rising in the West.
Diseases, Conditions, Syndromes
Jan 25, 2013 |
5 / 5 (1) |
0
BMJ editor urges Roche to fulfil promise to release Tamiflu trial data
In an open letter to company director, Professor Sir John Bell, she says: "Billions of pounds of public money have been spent on [Tamiflu] and yet the evidence on its effectiveness and safety remains hidden from appropriate ...
Medications
Oct 30, 2012 |
not rated yet |
0
Oseltamivir
Oseltamivir (INN) (pronounced /ɒsəlˈtæmɨvɪr/) is a drug that blocks the influenza virus from spreading between cells in the body. Thus it is an antiviral drug that is used in the treatment and prophylaxis of both Influenzavirus A and Influenzavirus B infection. Like zanamivir, oseltamivir is a neuraminidase inhibitor. It acts as a transition-state analogue inhibitor of influenza neuraminidase, preventing progeny virions from detaching from infected cells.
Oseltamivir was the first orally active neuraminidase inhibitor commercially developed. It is a prodrug, which is hydrolysed hepatically to the active metabolite, the free carboxylate of oseltamivir (GS4071). It was developed by US-based Gilead Sciences and is currently marketed by Hoffmann–La Roche (Roche) under the trade name Tamiflu. In Japan, it is marketed by Chugai Pharmaceutical Co., which is more than 50% owned by Roche. Oseltamivir is generally available by prescription only.
Roche estimates that 50 million people have been treated with oseltamivir. The majority of these have been in Japan, where an estimated 35 million have been treated. Since June 2009, Roche has been forced to allow other companies to develop competing drugs to Tamiflu, after much speculation about Roche's so-called 'monopoly' of Tamiflu in the UK.[citation needed]
For more information about Oseltamivir, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
